
Opinion|Videos|March 14, 2025
Recent Medical Advancements: Opportunities and Considerations
Author(s)Daniel E. Kremens, MD, JD
An expert discusses the extended form of carbidopa/levodopa (Crexont) for managing OFF episodes, highlighting trial results that show decreased OFF time and increased ON time, as well as the use of subcutaneous loading of medications in Parkinson disease, which was well tolerated with skin issues as the main adverse effects and resulted in increased ON time without worsening dyskinesia.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Discontinuing Disease-Modifying Therapy in Older Patients With MS: John Corboy, MD
2
Stem Cell Therapy Versus Traditional Parkinson Treatments
3
What Clinicians Need to Know About Emerging Stem Cell Therapies for Parkinson Disease
4
Mapping the Clinical Trial Landscape for Stem Cell Therapies in Parkinson Disease
5













